Symptomatic and pre-symptomatic biomarkers for ALS therapy development.

Benatar M (invited speaker). Symptomatic and pre-symptomatic biomarkers for ALS therapy development. Johns Hopkins ALS Clinical Trials Unit, Jan, 2021. [PubMed Link]